Table 5 |
||
|
Percentage of CCSP-positive cells of lung tissue in each group ( |
||
|
Group |
Dosage (mg·kg-1) |
Percentage of CCSP-positive cells |
|
|
||
|
PD pretreatment |
1 |
40.2 ± 2.3 |
|
5 |
54 ± 3b |
|
|
10 |
63.5 ± 2.6f |
|
|
15 |
79 ± 3i |
|
|
PD treatment |
1 |
37.4 ± 2.4 |
|
5 |
46 ± 3c |
|
|
10 |
56.8 ± 2.4f |
|
|
15 |
70 ± 4j |
|
|
|
||
|
bP < 0.05 and cP < 0.01 vs. 1 mg·kg-1 PD group, fP < 0.01 vs. 5 mg·kg-1PD group, iP < 0.05 and jP < 0.01 vs. 10 mg·kg-1 PD group. |
||
|
Shiyu et al. BMC Cell Biology 2011 12:31 doi:10.1186/1471-2121-12-31 |
||